glp-1 landscape The Evolving of GLP-1s: What's Next? The GLP-1 trend: What the

There are GLP-1 receptor agonists available that are approved to treat either type 2 diabetes or obesity along with diet and exercise

Strategies to use GDNF gene vectors have not been successfully so far ( Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide are growth factors that can cross the bloodbrain barrier GLP-1 and GIP are peptide hormones and growth factors that play important physiological signaling roles to control cell metabolism and energy utilization (Zhang et al., 2020)

The age-dependent decline of GHK-Cu levels provides a compelling rationale for supplementation as a strategy to restore regenerative functions diminished during aging

There is no ethical way to study this, so the only responsible course of action is total avoidance